Ahmedabad: Global lifesciences company, Zydus Lifesciences Limited ... and Southeast Asian regions. Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Dahod Lok Sabha constituency has 9 candidates in the fray. The candidates contesting for the Dahod seat are 9. The assets and liabilities declared by each of the candidates are as follows - Bariya ...
The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...
If you are looking for a gadgets support center nearby to solve all your device problems, then we have you sorted with this best service center in Dahod. OPPO Service Center is one of the best service ...
Zydus Lifesciences on Wednesday said it is introducing a vaccine ... and people with immunosuppressive and chronic medical conditions. According to the World Health Organisation (WHO), seasonal ...
Zydus Lifesciences on Wednesday (February 26 ... and people with immunosuppressive and chronic medical conditions. According to the World Health Organisation, seasonal influenza results in ...
Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...
Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 mg. (USRLD: Duexis ...
As Notre Dame and NC State were beginning to take the floor for overtime on Sunday afternoon in Raleigh, a medical emergency in the stands delayed the action on the floor. Not much information is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results